GS Global Future Health Care Equity Ptf Base Cap $
Rating and Score (On 30/06/2026)
Rating
FIDA
Rating
ESG
FIDA Category
***Some functions are not available in this version.***
Register for free to unlock functions
Static data
Name | GS Global Future Health Care Equity Ptf Base Cap $ |
Typology | Funds and Sicav |
ISIN Code | LU2220395680 |
Sicav | Goldman Sachs Funds SICAV |
Registration country | - |
Country authorised for sale | |
Asset manager | |
Address | Prinses Beatrixlaan 35 2595-AK 'S GRAVENHAGE |
Phone | |
Web site | |
FIDA Category | |
Assogestioni category | |
EFAMA Category | Equity Health Care |
Priips | Yes |
Official benchmark | 100.00% - MSCI ACWI Health Care Net TR |
Start Date placement | 30/09/2020 |
Search by currency | Usd - us dollar |
Quotation currency | Usd - us dollar |
Status | Active |
Distribution policy | No |
Total asset value at 30/07/2026 | 3.73 mln USD |
Documentation |
Quotation evolution (From 31/07/2023 On 31/07/2026)
10.95
5.09
%
31/07/2026
Loading data
Quote
Quotation currency | Usd - us dollar |
Quotation frequency | Daily |
Last quotation | $10.95 (31/07/2026) |
% change | |
Last Price in Euro | €9.53 |
Investment Objective
The Portfolio seeks to provide capital growth over the longer term.The Portfolio will mostly hold shares or similar instruments relating to companies that are domiciled anywhere in the world which, in the view of the Investment Adviser, have the potential to be beneficiaries of evolving trends in the health care sector including, but not limited to, the beneficiaries and drivers of advancements in genomics, precision medicine, life extension and robotic surgery.The Portfolio's holdings will be concentrated and may have significant exposure to specific sectors including, but not limited to, healthcare and technology sectors.The Portfolio will not invest more than 33% of its net assets in other types of companies, money market instruments and non-share related instruments. The Portfolio may use derivative instruments for efficient portfolio management purposes, to help manage risks and for investment purposes in order to seek to increase return. A derivative instrument is a contract between two or more parties whose value depends on the rise and fall of other underlying assets.The Portfolio may invest, up to 30%, in mainland China equity securities directly through the Stock Connect scheme or the Renminbi qualified foreign institutional investor program, or indirectly through access products. Shares in the Portfolio may be redeemed daily (on each business day) on demand.The Portfolio is actively managed and references the MSCI ACWI Health Care Index (Total Return Net) (USD) (the "Benchmark") for the purposes of setting discretionary internal risk thresholds which may reference deviations from the Benchmark. The Investment Adviser has full discretion over the composition of the assets in the Portfolio. While the Portfolio will generally hold assets that are components of the Benchmark, it can invest in such components in different proportions, and it can hold assets which are not components of the Benchmark. Therefore returns may deviate materially from the performance |
Tax system
PIR compliant | No |
PEA compliant | No |
PEA-PME compliant | No |
Company registry
Asset manager | |
Phone | |
Web site | |
Address | Prinses Beatrixlaan 35 2595-AK 'S GRAVENHAGE |
The data and information covered by the Service are for the exclusive internal use of the User and may neither be transferred to third parties, nor circulated, disclosed or allowed to be disclosed, nor used on external information systems, without the written consent of FIDA and, when necessary, of the information sources.
